Turkey Develops First Fully Domestic Anti-Cancer Drug
Turkey's First Homegrown Anti-Cancer Drug Successfully Completes Phase 1 Trials
Turkey has achieved a major milestone in pharmaceutical innovation: the country’s first fully domestically developed anti-cancer drug has successfully completed its Phase 1 clinical trials.
Health Minister Kemal Memişoğlu announced that the molecule was developed entirely within the national scientific ecosystem, with contributions from Bosphorus University, Koç University Hospital, and Abdurrahman Yurtaslan Oncology Hospital. Early human trials demonstrated both high efficacy and safety, providing promising results for future stages.
Targeted Therapy with Advanced Technology
Research team leader Rana Şanlı highlighted that the drug employs targeted therapy principles, selectively attacking cancer cells while minimizing side effects. This approach enhances treatment effectiveness and opens the door to developing similar drugs for different types of cancer.
“Our platform allows the design of drugs that can focus precisely on cancer cells, reducing harm to healthy tissue and improving patient outcomes,” said Rana Şanlı.
Phase 1 Trials: Safety and Tolerability
The initial phase was conducted on patients with solid tumors and primarily focused on assessing safety and tolerability. If the drug successfully passes Phase 2 and Phase 3 trials, it could become the first fully Turkish-developed anti-cancer medication to reach the global market.
Expansion of Cancer Screening Programs
Alongside drug development, Turkey is expanding nationwide cancer screening initiatives. Free early detection programs for breast, cervical, and colorectal cancer reached approximately 7.7 million people last year. Out of these, suspicious cases were identified in 276,000 individuals, and early-stage disease was detected in around 28,000.
Artificial Intelligence in Diagnostics
The country is increasingly integrating artificial intelligence into diagnostic systems. Authorities report that AI-driven analysis improves accuracy in detecting cancer and enhances the efficiency of subsequent treatments.
Looking Ahead
This breakthrough demonstrates Turkey’s growing capabilities in medical research and drug development. The combination of innovative targeted therapies and advanced screening programs promises a brighter future for cancer treatment and patient care in the country.
